House Dems call on the FTC to in­ves­ti­gate po­ten­tial col­lu­sion among top three in­sulin man­u­fac­tur­ers

Strik­ing while the iron is hot, six House De­moc­rats sent a let­ter Thurs­day to the act­ing chair­woman of the FTC (10 days af­ter the FTC said it would crack down on phar­ma merg­ers), call­ing for an in­ves­ti­ga­tion in­to the po­ten­tial col­lu­sion of in­sulin mar­ket lead­ers Eli Lil­ly, Sanofi and No­vo Nordisk.

Led by Rep. Katie Porter of Cal­i­for­nia, the let­ter notes that the three com­pa­nies raised the prices of their in­sulins in lock­step, and be­tween 2012 and 2016, the price of in­sulin al­most dou­bled. Sen. Bernie Sanders (I-VT) and the late Rep. Eli­jah Cum­mings of Mary­land sent a let­ter to the FTC rais­ing sim­i­lar charges of col­lu­sion among the same three com­pa­nies in 2016.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER